Illumina has launched its Nextera Exome and Custom Enrichment Kits for sample preparation for next-gen sequencing. The kits require 50 nanograms of starting DNA. The exome kit targets more than 62 megabases of coding regions and untranslated regions, and provides 12-plex pre-enrichment sample pooling.
BGI has developed PDXomics, a filtering tool for cancer sequence data to classify reads of a tumor xenograft from reads from the host. According to BGI, the tool can be used to develop patient-derived xenografts.